HRTX SG&A Expense Growth
Heron Therapeutics Inc · SG&A Expense Growth
HRTX SG&A Expense Growth
Latest reported3.17%period ending
HRTX FY SG&A Growth (YoY) (0.00% → 3.17%)
Latest values, visible window
High-resolution chart · PNG
HRTX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.1687% | |
| -16.1399% | |
| -17.2233% | |
| 13.6808% | |
| 20.0351% | |
| -16.9057% | |
| 36.002% | |
| 14.256% | |
| 19.0066% | |
| 93.1453% | |
| 81.174% | |
| -8.9911% | |
| 519.166% | |
| 0% | |
| -11.8358% | |
| 7.1217% | |
| -13.9308% | |
| -7.9897% | |
| 31.3043% | |
| 0% | |
| 10.5426% | |
| 15.1786% | |
| -19.8856% | |
| 5.8449% | |
| -4.6491% | |
| -46.7231% | |
| 8.3333% | |
| -18.9189% | |
| -35.0877% | |
| 18.75% | |
| 12.9412% | |
| -51.4286% | |
| 98.8636% | |
| 79.5918% | |
| -3.9216% | |
| -23.8806% | |
| -2.8986% | |
| 53.3333% | |
| 0% |